Applied Genetic Technologies Corporation Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff

Enrollment ongoing in pediatric dose groups Interim data of all adult dose groups expected in 2H of 2020 GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 16, 2020 --.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lineage Cell Therapeutics (LCTX), Menlo Therapeutics (MNLO)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Principia Biopharma (PRNB), Constellation Pharmaceuticals

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Principia Biopharma

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech (KRYS) and Precision BioSciences (DTIL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TRACON Pharmaceuticals (TCON), Aduro BioTech (ADRO) and

Chardan Capital analyst Gbola Amusa reiterated a Hold rating on Voyager Therapeutics (VYGR) today and set a price target of $20.00. The company's shares

Chardan Capital analyst Gbola Amusa reiterated a Hold rating on Voyager Therapeutics (VYGR – Research Report) today and set a

In a report released today, Gbola Amusa from Chardan Capital reiterated a Hold rating on Amicus (FOLD), with a price target of $12.50. The company's

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK), Acceleron Pharma (XLRN) and Autolus

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on uniQure (QURE) today and set a price target of $105.00. The company's shares closed last